169 related articles for article (PubMed ID: 36450573)
1. Pediatric Invasive Aspergillosis: a Retrospective Review of 59 Cases.
Özen S; Özdemir H; Taşkin EÇ; Arga G; Konca HK; Çakmakli HF; Haskoloğlu Ş; Okulu E; Dinçaslan H; İnce E; İleri T; Taçyildiz N; Doğu F; Evren E; Us E; Karahan ZC; Fitöz S; Kendirli T; Kuloğlu Z; Tutar E; İkincioğullari A; Ünal E; Ertem M; İnce E; Çiftçi E
Jpn J Infect Dis; 2023 Mar; 76(2):113-119. PubMed ID: 36450573
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features and Survival Outcomes of Invasive Aspergillosis in Pediatric Patients at a Medical School in Thailand.
Anugulruengkitt S; Trinavarat P; Chantranuwat P; Sritippayawan S; Pancharoen C; Thanyawee P
J Med Assoc Thai; 2016 Feb; 99(2):150-8. PubMed ID: 27249894
[TBL] [Abstract][Full Text] [Related]
3. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
[TBL] [Abstract][Full Text] [Related]
4. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
[TBL] [Abstract][Full Text] [Related]
6. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
Herbrecht R; Patterson TF; Slavin MA; Marchetti O; Maertens J; Johnson EM; Schlamm HT; Donnelly JP; Pappas PG
Clin Infect Dis; 2015 Mar; 60(5):713-20. PubMed ID: 25414266
[TBL] [Abstract][Full Text] [Related]
7. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
Resendiz-Sharpe A; Mercier T; Lestrade PPA; van der Beek MT; von dem Borne PA; Cornelissen JJ; De Kort E; Rijnders BJA; Schauwvlieghe AFAD; Verweij PE; Maertens J; Lagrou K
J Antimicrob Chemother; 2019 Sep; 74(9):2759-2766. PubMed ID: 31236587
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
Le Clech L; Uguen M; Quinio D; Nevez G; Couturier MA; Ianotto JC; Berthou C; Guillerm G; Le Bars H; Payan C; Narbonne V; Baron R; Saliou P
Curr Res Transl Med; 2020 Jan; 68(1):23-28. PubMed ID: 31787568
[TBL] [Abstract][Full Text] [Related]
10. Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France.
Denis B; Guiguet M; de Castro N; Mechaï F; Revest M; Melica G; Costagliola D; Lortholary O;
Clin Infect Dis; 2015 Oct; 61(8):1273-80. PubMed ID: 26123932
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study.
Mariette C; Tavernier E; Hocquet D; Huynh A; Isnard F; Legrand F; Lhéritier V; Raffoux E; Dombret H; Ifrah N; Cahn JY; Thiébaut A
Leuk Lymphoma; 2017 Mar; 58(3):586-593. PubMed ID: 27397551
[TBL] [Abstract][Full Text] [Related]
12. Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study.
Glampedakis E; Cassaing S; Fekkar A; Dannaoui E; Bougnoux ME; Bretagne S; Neofytos D; Schreiber PW; Hennequin C; Morio F; Shadrivova O; Bongomin F; Fernández-Ruiz M; Bellanger AP; Arikan-Akdagli S; Erard V; Aigner M; Paolucci M; Khanna N; Charpentier E; Bonnal C; Brun S; Gabriel F; Riat A; Zbinden R; Le Pape P; Klimko N; Lewis RE; Richardson M; İnkaya AC; Coste AT; Bochud PY; Lamoth F
Clin Infect Dis; 2021 Apr; 72(8):1379-1385. PubMed ID: 32155262
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.
Hsu AJ; Tamma PD; Fisher BT
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0215621. PubMed ID: 35766509
[TBL] [Abstract][Full Text] [Related]
14. Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
Racil Z; Weinbergerova B; Kocmanova I; Muzik J; Kouba M; Drgona L; Masarova L; Guman T; Tothova E; Forsterova K; Haber J; Ziakova B; Bojtarova E; Vydra J; Mudry P; Foralova R; Sejnova D; Mallatova N; Kandrnal V; Cetkovsky P; Mayer J
Int J Infect Dis; 2013 Feb; 17(2):e101-9. PubMed ID: 23084969
[TBL] [Abstract][Full Text] [Related]
15. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
[TBL] [Abstract][Full Text] [Related]
16. Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.
Dib RW; Hachem RY; Chaftari AM; Ghaly F; Jiang Y; Raad I
BMC Infect Dis; 2018 Dec; 18(1):656. PubMed ID: 30545320
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience.
Al Dhaheri F; Lee RA; Sharma TS; Nakamura MM; Marty FM
Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35138378
[TBL] [Abstract][Full Text] [Related]
18. The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review.
van de Peppel RJ; Visser LG; Dekkers OM; de Boer MGJ
J Infect; 2018 Jun; 76(6):550-562. PubMed ID: 29727605
[TBL] [Abstract][Full Text] [Related]
19. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
20. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.
Lafaurie M; Lapalu J; Raffoux E; Breton B; Lacroix C; Socié G; Porcher R; Ribaud P; Touratier S; Molina JM
Clin Microbiol Infect; 2010 Aug; 16(8):1191-6. PubMed ID: 19735276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
